Source:http://linkedlifedata.com/resource/pubmed/id/11756339
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-12-28
|
pubmed:abstractText |
Mesangial cells isolated from NOD mice after the onset of diabetes have undergone a stable phenotypic change. This phenotype is characterized by increased expression of IGF-I and downregulation of collagen degradation, which is associated with decreased MMP-2 activity. Here, we investigated the IGF-I signaling pathway in mesangial cells isolated from NOD mice before (nondiabetic NOD mice [ND-NOD]) and after (diabetic NOD mice [D-NOD]) the onset of diabetes. We found that the IGF-I signaling pathway in D-NOD cells was activated by autocrine IGF-I. They had phosphorylation of the IGF-I receptor beta-subunit, phosphorylation of insulin receptor substrate (IRS)-1, and association of the p85 subunit (phosphatidylinositol 3-kinase [PI3K]) with the IGF-I receptor and IRS-1 in D-NOD cells in the basal state. This was also associated with increased phosphorylation of ERK2 in D-NOD mesangial cells. Inhibiting autocrine IGF-I from binding to its receptor using an IGF-I-neutralizing antibody or inhibiting IGF-I signaling pathways using a specific PI3K inhibitor or a specific mitogen-activated protein kinase/extracellular response kinase kinase inhibitor decreased phosphorylated ERKs in D-NOD cells. Importantly, this was associated with increased MMP-2 activity. The addition of exogenous IGF-I to ND-NOD activated signal transduction. Therefore, we conclude that the IGF-I signaling pathway is intact in both D-NOD and ND-NOD cells. However, the phenotypic change in D-NOD cells is associated with constitutive activation of the IGF-I signaling pathways, which may participate in the development and progression of diabetic glomerulosclerosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinases,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
182-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11756339-Analysis of Variance,
pubmed-meshheading:11756339-Animals,
pubmed-meshheading:11756339-Cell Culture Techniques,
pubmed-meshheading:11756339-Cell Line,
pubmed-meshheading:11756339-Diabetes Mellitus, Type 1,
pubmed-meshheading:11756339-Enzyme Inhibitors,
pubmed-meshheading:11756339-Glomerular Mesangium,
pubmed-meshheading:11756339-Insulin-Like Growth Factor I,
pubmed-meshheading:11756339-MAP Kinase Signaling System,
pubmed-meshheading:11756339-Matrix Metalloproteinases,
pubmed-meshheading:11756339-Mice,
pubmed-meshheading:11756339-Mice, Inbred NOD,
pubmed-meshheading:11756339-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:11756339-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:11756339-Mitogen-Activated Protein Kinases,
pubmed-meshheading:11756339-Phosphorylation,
pubmed-meshheading:11756339-Receptor, IGF Type 1,
pubmed-meshheading:11756339-Reference Values,
pubmed-meshheading:11756339-Signal Transduction
|
pubmed:year |
2002
|
pubmed:articleTitle |
Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice.
|
pubmed:affiliation |
Physiology Laboratory, University of Toulouse School of Medicine, Toulouse, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|